Cargando…

Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives

Excessive sleepiness (ES) is a symptom of obstructive sleep apnea (OSA) and narcolepsy that has severe consequences. Wake-promoting drugs and stimulants are utilized as accessory treatment in OSA to reduce propensity to sleep but they do not improve sleep-disordered breathing. Solriamfetol is a firs...

Descripción completa

Detalles Bibliográficos
Autor principal:	Abad, Vivien C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846869/ https://www.ncbi.nlm.nih.gov/pubmed/33531850 http://dx.doi.org/10.2147/NSS.S245020

Ejemplares similares

A randomized study of solriamfetol for excessive sleepiness in narcolepsy
por: Thorpy, Michael J., et al.
Publicado: (2019)

Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea
por: Malhotra, Atul, et al.
Publicado: (2019)

Effects of solriamfetol on on‐the‐road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea
por: Vinckenbosch, Frederick, et al.
Publicado: (2022)

Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial
por: Videnovic, Aleksandar, et al.
Publicado: (2021)

Excessive Daytime Sleepiness in Obstructive Sleep Apnea. Mechanisms and Clinical Management
por: Lal, Chitra, et al.
Publicado: (2021)

Psychomotor Vigilance Performance in Participants with Excessive Daytime Sleepiness in Obstructive Sleep Apnea or Narcolepsy Compared with SAFTE-FAST Model Predictions
por: Devine, Jaime K., et al.
Publicado: (2022)

Risk of obstructive sleep apnea and excessive daytime sleepiness in hospitalized psychiatric patients
por: Talih, Farid R, et al.
Publicado: (2017)

Sex Differences in Excessive Daytime Sleepiness Among Patients With Obstructive Sleep Apnea
por: Lee, Sang-Ahm, et al.
Publicado: (2022)

Association between excessive daytime sleepiness, REM phenotype and severity of obstructive sleep apnea
por: Gabryelska, Agata, et al.
Publicado: (2020)

Randomized Controlled Trial of Solriamfetol for Excessive Daytime Sleepiness in OSA: An Analysis of Subgroups Adherent or Nonadherent to OSA Treatment
por: Schweitzer, Paula K., et al.
Publicado: (2021)

Examining the impact of excessive daytime sleepiness on utility scores in patients with obstructive sleep apnoea and/or narcolepsy in five European countries
por: Cambron-Mellott, M. Janelle, et al.
Publicado: (2022)

Gender differences in the sleep variables contributing to excessive daytime sleepiness among patients with obstructive sleep apnea
por: Honig, Eliya, et al.
Publicado: (2021)

Relationship between sleep efficacy endpoints and measures of functional status and health‐related quality of life in participants with narcolepsy or obstructive sleep apnea treated for excessive daytime sleepiness
por: Weaver, Terri E., et al.
Publicado: (2020)

Obstructive Sleep Apnea With or Without Excessive Daytime Sleepiness: Clinical and Experimental Data-Driven Phenotyping
por: Garbarino, Sergio, et al.
Publicado: (2018)

Altered irisin/BDNF axis parallels excessive daytime sleepiness in obstructive sleep apnea patients
por: More, Csaba E., et al.
Publicado: (2019)

Excessive Daytime Sleepiness in Depression and Obstructive Sleep Apnea: More Than Just an Overlapping Symptom
por: Zhang, Danwei, et al.
Publicado: (2021)

O029 Sleep architecture differs for individuals manifesting excessive daytime sleepiness with and without obstructive sleep apnea
por: Chen, X, et al.
Publicado: (2022)

Risk of obstructive sleep apnea, excessive daytime sleepiness and depressive symptoms in a Nigerian elderly population
por: Fawale, Michael B., et al.
Publicado: (2016)

Understanding the burden of illness of excessive daytime sleepiness associated with obstructive sleep apnea: a qualitative study
por: Waldman, Laura Tesler, et al.
Publicado: (2020)

Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility
por: Guevarra, Jay T, et al.
Publicado: (2020)

Lisdexamfetamine to improve excessive daytime sleepiness and weight management in narcolepsy: a case series
por: Aguilar, Ana C., et al.
Publicado: (2019)

Solriamfetol for the Use of Narcolepsy: A Systematic Review
por: Iturburu, Alisson, et al.
Publicado: (2022)

The Association between the Phenotype of Excessive Daytime Sleepiness and Blood Pressure in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome
por: Wang, Qimin, et al.
Publicado: (2014)

Excessive daytime sleepiness and metabolic syndrome in men with obstructive sleep apnea: a large cross-sectional study
por: Fu, Yiqun, et al.
Publicado: (2017)

Current Management of Residual Excessive Daytime Sleepiness Due to Obstructive Sleep Apnea: Insights for Optimizing Patient Outcomes
por: Mehra, Reena, et al.
Publicado: (2021)

Interaction between apolipoprotein E genotypes, excessive daytime sleepiness, and cognitive function in obstructive sleep apnea patients
por: Balthazar, Fernanda Maurer, et al.
Publicado: (2022)

Excessive Daytime Sleepiness in Obstructive Sleep Apnea Patients Treated With Continuous Positive Airway Pressure: Data From the European Sleep Apnea Database
por: Bonsignore, Maria R., et al.
Publicado: (2021)

Cortical thinning in male obstructive sleep apnoea patients with excessive daytime sleepiness
por: Li, Yezhou, et al.
Publicado: (2023)

The Role of Daytime Sleepiness in Psychosocial Outcomes after Treatment for Obstructive Sleep Apnea
por: Lau, Esther Yuet Ying, et al.
Publicado: (2013)

Prevalence of childhood obstructive sleep apnea syndrome and its role in daytime sleepiness
por: Tsukada, Eriko, et al.
Publicado: (2018)

Reduced Cross-Frequency Coupling and Daytime Sleepiness in Obstructive Sleep Apnea Patients
por: Gouveris, Haralampos, et al.
Publicado: (2022)

High-risk of obstructive sleep apnea and excessive daytime sleepiness among commercial intra-city drivers in Lagos metropolis
por: Ozoh, Obianuju B., et al.
Publicado: (2013)

Obstructive sleep apnea with excessive daytime sleepiness is associated with non-alcoholic fatty liver disease regardless of visceral fat
por: Yu, Ji Hee, et al.
Publicado: (2015)

Risk Assessment for Self Reported Obstructive Sleep Apnea and Excessive Daytime Sleepiness in a Greek Nursing Staff Population
por: Alexandropoulou, Alexia, et al.
Publicado: (2019)

Inspiratory Muscle Training in the Severity of Obstructive Sleep Apnea, Sleep Quality and Excessive Daytime Sleepiness: A Placebo-Controlled, Randomized Trial
por: Nóbrega-Júnior, José Carlos Nogueira, et al.
Publicado: (2020)

P020 Reduced duration and continuity of N3 sleep is associated with excessive daytime sleepiness in suspected obstructive sleep apnea patients
por: Chen, X, et al.
Publicado: (2021)

Pharmacological Interventions for Excessive Daytime Sleepiness in Adults with Narcolepsy: A Systematic Review and Network Meta-Analysis
por: Chien, Po-Yu, et al.
Publicado: (2022)

The Relative Association of Obstructive Sleep Apnea, Obesity, and Excessive Daytime Sleepiness with Incident Depression: A Longitudinal, Population-based Study
por: LaGrotte, Caitlin, et al.
Publicado: (2016)

Association of Excessive Daytime Sleepiness with the Zung Self-Rated Depression Subscales in Adults with Coronary Artery Disease and Obstructive Sleep Apnea
por: Celik, Yeliz, et al.
Publicado: (2021)

Correlates of excessive daytime sleepiness in obstructive sleep apnea: Results from the nationwide SESAR cohort including 34,684 patients
por: Ulander, Martin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_87f1ui3n8lp7ghu5r3mlvq2bit